Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants
Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants
Recruiting · NCT07419698 · Registry updated 2026-02-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants | Healthy Participants | Recruiting | Phase 1 | 2026-02-19 | NCT07419698 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai JMT-Bio Inc. | 30 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BeiJing Cancer Hospital EC | Beijing | China | 2 |